SB1013 would amend Arizona’s probation statute for drug possession and paraphernalia offenses to make people convicted of personal possession or use of fentanyl ineligible for probation under A.R.S. § 13-901.01. Under current law, most first- and second-time simple possession cases are probation-eligible and must include treatment or education; this bill adds fentanyl to the list of offenses that trigger ineligibility, alongside methamphetamine, while preserving an exception for a valid medical prescription for fentanyl. The bill also keeps existing rules that allow incarceration or other sentencing under general felony provisions when probation is refused, treatment is rejected, or the person has prior qualifying convictions.
The measure includes legislative findings explaining that fentanyl has become a major driver of overdose deaths in Arizona and that stronger penalties are intended to deter use, improve treatment compliance, and reduce harm to families, first responders, and communities. It also states that the change is meant to mirror the policy approach previously adopted for methamphetamine.
If enacted, SB1013 would directly amend A.R.S. § 13-901.01, narrowing the class of drug-possession defendants who are automatically eligible for probation and treatment-based sentencing. It would give courts authority to sentence first- and second-time fentanyl possession offenders under the general criminal sentencing provisions instead of the probation-only framework that applies to most other simple possession cases. The bill also declares that the change requires a three-fourths vote of each legislative chamber to take effect.
The overall sentiment reflected in the voting history is mixed but leans supportive in committee and divided on the floor. The bill advanced through the Senate and several House committees, including a favorable House Judiciary vote, but it ultimately failed on House third reading by a narrow margin. That pattern suggests substantial concern remained even among lawmakers willing to move it forward in committee.
The main point of contention is the policy choice to treat fentanyl possession more harshly than other controlled-substance possession offenses by removing automatic probation eligibility. Supporters appear to view fentanyl as uniquely lethal and deserving of stronger deterrence, while opponents likely object to expanding incarceration for drug possession and to departing from Arizona’s treatment-oriented probation model. The bill’s narrow House defeat indicates that the balance between public safety, treatment, and sentencing severity was the central dispute.
Impact
SB1013 would amend A.R.S. § 13-901.01, Arizona’s main probation statute for personal possession or use of controlled substances and drug paraphernalia, by adding fentanyl to the list of drugs that make a defendant ineligible for probation under that section. As a result, first- and second-time fentanyl possession cases would no longer be governed by the statute’s mandatory probation-and-treatment framework and could instead be sentenced under the general felony sentencing provisions. The bill preserves an exception for valid fentanyl prescriptions and leaves existing rules intact for methamphetamine, violent crimes, repeated convictions, refusal of treatment, and other probation violations.
Sentiment
The bill’s sentiment appears generally supportive in committee but sharply divided overall. It passed several committee stages in both chambers, including a favorable House Judiciary vote, indicating that many lawmakers accepted the premise that fentanyl warrants a tougher legal response. However, the House third-reading vote failed, showing that enough members opposed the measure to block final passage. The voting pattern suggests a split between those prioritizing deterrence and public safety and those concerned about expanding incarceration for drug possession.
Contention
The central contention is whether fentanyl possession should be removed from Arizona’s probation-first, treatment-oriented approach to simple drug possession. Supporters argue fentanyl is uniquely deadly, is driving overdose deaths, and requires stronger penalties to deter use and encourage compliance with treatment. Opponents are likely concerned that the bill increases incarceration for drug users, reduces judicial flexibility, and departs from the state’s established model of diverting low-level possession cases into probation and treatment. The narrow House defeat indicates that this policy tradeoff was highly contested.